These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets. Williams KA, Murphy W, Haslam RJ. Biochem J; 1987 May 01; 243(3):667-78. PubMed ID: 2444206 [Abstract] [Full Text] [Related]
7. Effects of forskolin and organic nitrate on aggregation and intracellular cyclic nucleotide content in human platelets. Anfossi G, Massucco P, Mularoni E, Cavalot F, Mattiello L, Trovati M. Gen Pharmacol; 1994 Oct 01; 25(6):1093-100. PubMed ID: 7875530 [Abstract] [Full Text] [Related]
9. Effects of the cAMP-elevating agents cilostamide, cilostazol and forskolin on the phosphorylation of Akt and GSK-3beta in platelets. Hayashi H, Sudo T. Thromb Haemost; 2009 Aug 01; 102(2):327-35. PubMed ID: 19652884 [Abstract] [Full Text] [Related]
11. Agents that elevate platelet cAMP stimulate the formation of phosphatidylinositol 4-phosphate in intact human platelets. de Chaffoy de Courcelles D, Roevens P, van Belle H. FEBS Lett; 1986 Jan 20; 195(1-2):115-8. PubMed ID: 2417883 [Abstract] [Full Text] [Related]
12. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions. Bilodeau ML, Hamm HE. J Pharmacol Exp Ther; 2007 Aug 20; 322(2):778-88. PubMed ID: 17525299 [Abstract] [Full Text] [Related]
14. Preliminary studies of a platelet function disorder in Simmental cattle. Searcy GP, Sheridan D, Dobson KA. Can J Vet Res; 1990 Jun 20; 54(3):394-6. PubMed ID: 2379119 [Abstract] [Full Text] [Related]
15. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor. Merritt JE, Hallam TJ, Brown AM, Boyfield I, Cooper DG, Hickey DM, Jaxa-Chamiec AA, Kaumann AJ, Keen M, Kelly E. Br J Pharmacol; 1991 Jan 20; 102(1):251-9. PubMed ID: 1710526 [Abstract] [Full Text] [Related]